Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis
- 27 January 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 106 (2), 263-271
- https://doi.org/10.1007/s10549-006-9491-6
Abstract
A reduced activity of methylenetetrahydrofolate reductase (MTHFR) due to frequent C677T polymorphism affects DNA synthesis, repair and methylation and may be implicated in breast cancer risk.Keywords
This publication has 39 references indexed in Scilit:
- Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risksBreast Cancer Research and Treatment, 2006
- Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in TaiwanCarcinogenesis: Integrative Cancer Research, 2006
- One-Carbon Metabolism and Breast Cancer Risk: No Association ofMTHFR, MTR, andTYMSPolymorphisms in the GENICA Study from GermanyCancer Epidemiology, Biomarkers & Prevention, 2005
- No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancerCell Biochemistry and Function, 2005
- The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern GreeceCancer Letters, 2005
- One-Carbon Metabolism,MTHFRPolymorphisms, and Risk of Breast CancerCancer Research, 2005
- Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean womenExperimental & Molecular Medicine, 2004
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986